YCBD
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when cbdMD, Inc. publishes a filing, an earnings call transcript or a press release.
Get YCBD alertsRonan Kennedy is recorded as CFO at cbdMD, Inc. (YCBD). The proxy statement of cbdMD, Inc. reports total compensation of $275,000 for Ronan Kennedy in fiscal 2024, including a base salary of $275,000. Disclosed compensation is on record for 3 fiscal years. Ronan Kennedy has spoken on 10 earnings calls across 1 company, most recently for cbdMD, Inc. on August 13, 2026. cbdMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at cbdMD, Inc. includes Martin A (CEO), Martin A. Sumichrast (CEO and Board Member), R. Scott (CEO) and 7 others.
“The third quarter of fiscal 2026 was another quarter of top-line growth and one of the most active periods we've had, both in our own business and across the regulatory landscape we operate in.”
“Over the past several quarters, we set two clear goals: one, drive revenue growth and achieve profitability; and two, resolve our capital structure and regain compliance with the NYSE American listing standards.”
“On our last call, we laid out two corporate priorities: achieving profitability and resolving our capital structure and listing challenges. I'm thrilled to be speaking with you today not only to report on a historic quarter but to highlight the stronger foundation we've built and the exciting opportunities ahead.”
“On our last call, I discussed key initiatives designed to propel the company forward on our path to profitability. Over the past few months, we've been fully focused on executing this plan and delivering measurable results.”
“Our results in the second quarter show that we are building the right strategic plans and the right team to deliver on results.”
YCBD
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | cbdMD, Inc. (YCBD) | CEO and CFO | $275,000 | $275,000 |
| 2023 | cbdMD, Inc. (YCBD) | CEO and CFO | $275,000 | $275,000 |
| 2022 | cbdMD, Inc. (YCBD) | Interim CEO and CFO CFO and COO | $275,962 | $557,712 |